MUTUAL OF AMERICA CAPITAL MANAGEMENT LLC - CATALYST PHARMACEUTICALS INC ownership

CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 254 filers reported holding CATALYST PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.94 and the average weighting 0.1%.

Quarter-by-quarter ownership
MUTUAL OF AMERICA CAPITAL MANAGEMENT LLC ownership history of CATALYST PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$205,276
-19.8%
17,560
-7.8%
0.00%0.0%
Q2 2023$255,938
-21.7%
19,043
-3.4%
0.00%
-25.0%
Q1 2023$326,908
-12.4%
19,717
-1.7%
0.00%
-20.0%
Q4 2022$373,209
+54.9%
20,065
+6.6%
0.01%
+66.7%
Q3 2022$241,00018,8190.00%
Other shareholders
CATALYST PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
TANAKA CAPITAL MANAGEMENT INC 589,883$590,0001.38%
Broadfin Capital, LLC 8,200,000$8,610,0000.96%
Avoro Capital Advisors LLC 1,141,149$1,198,0000.24%
CORRADO ADVISORS, LLC 190,600$200,0000.12%
Baker Brothers Advisors 5,102,153$5,357,0000.05%
KINGDON CAPITAL MANAGEMENT, L.L.C. 756,311$794,0000.04%
Point72 Asset Management, L.P. 2,272,816$2,386,0000.02%
AGRAN LIBBIE 44,000$46,0000.01%
COMPTON CAPITAL MANAGEMENT INC /RI 10,000$11,0000.01%
KENNEDY CAPITAL MANAGEMENT LLC 233,171$245,0000.00%
View complete list of CATALYST PHARMACEUTICALS INC shareholders